Pharmaceutical

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.

Aug 22, 2023 - 20:00
AI drug discovery company Genesis Therapeutics wins $200m in Series B round
The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.
Read the original article

Tags:

Previous Article

Leo Pharma to acquire US company Timber Pharmaceuticals

Next Article

Roche And Exelixis’ Drug Combo Grabs Late-Stage Prostate Cancer Victory

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

‘We’re absolutely making it too hard’: The complexity of adult immunization delivery hinders vaccine uptake

‘We’re absolutely making it too hard’: The complexity o...

Oct 26, 2023

STAT+: Pharmalittle: Novartis is latest drugmaker to sue over Medicare negotiations; Illumina names a new CEO

STAT+: Pharmalittle: Novartis is latest drugmaker to su...

Sep 6, 2023

Which drugs are most likely to be approved in Stem Cell...

Mar 28, 2024